193 related articles for article (PubMed ID: 32391613)
1. Targeting telomerase for its advent in cancer therapeutics.
Bajaj S; Kumar MS; Peters GJ; Mayur YC
Med Res Rev; 2020 Sep; 40(5):1871-1919. PubMed ID: 32391613
[TBL] [Abstract][Full Text] [Related]
2. Telomerase Inhibitors from Natural Products and Their Anticancer Potential.
Ganesan K; Xu B
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267203
[TBL] [Abstract][Full Text] [Related]
3. Telomerase inhibition, telomere attrition and proliferation arrest of cancer cells induced by phosphorothioate ASO-NLS conjugates targeting hTERC and siRNAs targeting hTERT.
Diala I; Shiohama Y; Fujita T; Kotake Y; Demonacos C; Krstic-Demonacos M; Leva GD; Fujii M
Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):407-425. PubMed ID: 32310030
[TBL] [Abstract][Full Text] [Related]
4. Ectopic expression of human telomerase RNA component results in increased telomerase activity and elongated telomeres in bovine blastocysts.
Garrels W; Kues WB; Herrmann D; Holler S; Baulain U; Niemann H
Biol Reprod; 2012 Oct; 87(4):95. PubMed ID: 22855562
[TBL] [Abstract][Full Text] [Related]
5. Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors.
Saraswati AP; Relitti N; Brindisi M; Gemma S; Zisterer D; Butini S; Campiani G
Drug Discov Today; 2019 Jul; 24(7):1370-1388. PubMed ID: 31136800
[TBL] [Abstract][Full Text] [Related]
6. Telomerase reverse transcriptase in the regulation of gene expression.
Zhou J; Ding D; Wang M; Cong YS
BMB Rep; 2014 Jan; 47(1):8-14. PubMed ID: 24388106
[TBL] [Abstract][Full Text] [Related]
7. 1,3,4-Oxadiazoles as Telomerase Inhibitor: Potential Anticancer Agents.
Bajaj S; Roy PP; Singh J
Anticancer Agents Med Chem; 2018 Feb; 17(14):1869-1883. PubMed ID: 28443517
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.
Suenaga M; Soda H; Oka M; Yamaguchi A; Nakatomi K; Shiozawa K; Kawabata S; Kasai T; Yamada Y; Kamihira S; Tei C; Kohno S
Int J Cancer; 2002 Feb; 97(5):621-5. PubMed ID: 11807787
[TBL] [Abstract][Full Text] [Related]
9. Potential Telomere-Related Pharmacological Targets.
Berei J; Eckburg A; Miliavski E; Anderson AD; Miller RJ; Dein J; Giuffre AM; Tang D; Deb S; Racherla KS; Patel M; Vela MS; Puri N
Curr Top Med Chem; 2020; 20(6):458-484. PubMed ID: 31916516
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
11. Mild hyperoxia limits hTR levels, telomerase activity, and telomere length maintenance in hTERT-transduced bone marrow endothelial cells.
Napier CE; Veas LA; Kan CY; Taylor LM; Yuan J; Wen VW; James A; O'Brien TA; Lock RB; MacKenzie KL
Biochim Biophys Acta; 2010 Oct; 1803(10):1142-53. PubMed ID: 20619302
[TBL] [Abstract][Full Text] [Related]
12. DNA Methylation Profiling of hTERT Gene Alongside with the Telomere Performance in Gastric Adenocarcinoma.
Vahidi S; Norollahi SE; Agah S; Samadani AA
J Gastrointest Cancer; 2020 Sep; 51(3):788-799. PubMed ID: 32617831
[TBL] [Abstract][Full Text] [Related]
13. How to inhibit telomerase activity for cancer therapy.
Kyo S; Inoue M
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728
[TBL] [Abstract][Full Text] [Related]
14. Expression of human telomerase reverse transcriptase mediates the senescence of mesenchymal stem cells through the PI3K/AKT signaling pathway.
Zhao Q; Wang XY; Yu XX; Zhai YX; He X; Wu S; Shi YA
Int J Mol Med; 2015 Sep; 36(3):857-64. PubMed ID: 26178664
[TBL] [Abstract][Full Text] [Related]
15. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
Babizhayev MA; Yegorov YE
J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
[TBL] [Abstract][Full Text] [Related]
16. Telomere shortening and cell senescence induced by perylene derivatives in A549 human lung cancer cells.
Taka T; Huang L; Wongnoppavich A; Tam-Chang SW; Lee TR; Tuntiwechapikul W
Bioorg Med Chem; 2013 Feb; 21(4):883-90. PubMed ID: 23321015
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas - a systematic review.
Stögbauer L; Stummer W; Senner V; Brokinkel B
Neurosurg Rev; 2020 Jun; 43(3):903-910. PubMed ID: 30788677
[TBL] [Abstract][Full Text] [Related]
18. Targeting human telomerase in cancer therapy.
Huard S; Autexier C
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725
[TBL] [Abstract][Full Text] [Related]
19. Telomere and Telomerase Therapeutics in Cancer.
Xu Y; Goldkorn A
Genes (Basel); 2016 May; 7(6):. PubMed ID: 27240403
[TBL] [Abstract][Full Text] [Related]
20. Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors.
Zhu K; Qu D; Sakamoto T; Fukasawa I; Hayashi M; Inaba N
Arch Gynecol Obstet; 2008 Jan; 277(1):15-9. PubMed ID: 17680259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
